Associate Professor of Obstetrics and Gynecology, Oregon Health and Sci University
Obstetrics & Gynecology
Dr. Tanja B. Pejovic, MD
|
|
Give Review
Tanja Pejovic practices Obstetrics & Gynecology. She received awards:"America's Top Doctors", "America's Top Doctors for Cancer", "Portland Monthly Magazine", "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACOG)". Tanja Pejovic is a published doctor and has 66 publications published. The lastest was: 'Cytogenetics of uterine sarcomas: presentation of eight new cases and review of the literature.' Tanja B. Pejovic accepts Medicare payments and is registered with Medicare.gov.
Publications
- Nestin: A biomarker of aggressive uterine Cancers.
- Common variants at the CHEK2 gene locus and risk of epithelial ovarian Cancer.
- NPPB is a novel candidate biomarker expressed by Cancer-associated fibroblasts in epithelial ovarian Cancer.
- New insights in the pathophysiology of ovarian Cancer and implications for screening and prevention.
- Evaluating the ovarian Cancer gonadotropin hypothesis: A candidate gene study.
- Stromal Expression of Fibroblast Activation Protein Alpha (FAP) Predicts Platinum Resistance and Shorter Recurrence in patients with Epithelial Ovarian Cancer.
- Identification of novel candidate biomarkers of epithelial ovarian Cancer by profiling the Secretomes of three-dimensional genetic models of ovarian carcinogenesis.
- ABCA transporter gene expression and poor outcome in epithelial ovarian Cancer.
- Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian Cancer outcome.
- Expression of DNA repair proteins in endometrial Cancer predicts disease outcome.
- Clinical Implications of Marker Expression of Carcinoma-Associated Fibroblasts (CAFs) in Patients with Epithelial Ovarian Carcinoma After Treatment with Neoadjuvant Ch...
- Trefoil factor family 3 (TFF3) expression and its interaction with estrogen receptor (ER) in endometrial adenoCarcinoma.
- ER(+) /PR(+) /TFF3(+) /IMP3(-) immunoprofile distinguishes endometrioid from serous and clear cell Carcinomas of the endometrium: a study of 401 cases.
- MET/HGF Signaling Pathway in Ovarian Carcinoma: Clinical Implications and Future Direction.
- Histologic parameters predictive of disease outcome in women with advanced stage ovarian Carcinoma treated with neoadjuvant chemotherapy.
- Role of minimally invasive surgery in ovarian Cancer.
- Frequent MAGE mutations in Human melanoma.
- Analysis of chemotherapy response programs in ovarian Cancers by the next-generation sequencing technologies.
- Expression profiling of the Ovarian surface kinome reveals candidate genes for early neoplastic changes.
- Ovulation in the absence of the Ovarian surface epithelium in the primate.
- The relationship of Endometriosis and ovarian malignancy: a review.
- Array-comparative genomic hybridization analysis of primary endometrial and ovarian high-grade neuroendocrine Carcinoma associated with adenoCarcinoma: mystery resolved?
- Array-based comparative genomic hybridization (aCGH) analysis is a useful tool for distinguishing primary pulmonary from metastatic neuroendocrine Carcinoma to the lung.
- Induction of proliferation in the primate Ovarian surface epithelium in vivo.
- Cytogenetic instability in ovarian epithelial cells from women at risk of ovarian Cancer.
- Induction of ovulation and ovarian Cancer: a critical review of the literature.
- Somatic D-loop mitochondrial DNA mutations are frequent in uterine serous Carcinoma.
- Identification of differentially expressed genes in clinically distinct groups of serous ovarian Carcinomas using cDNA microarray.
- Comparative genomic hybridization study of placental site trophoblastic tumour: a report of four cases.
- Whole genome analysis of genetic alterations in small DNA samples using hyperbranched strand displacement amplification and array-CGH.
- Leukemias.
- Claudin7 and moesin in endometrial AdenoCarcinoma; a retrospective study of 265 patients.
- BRCAness Profile of Sporadic Ovarian Cancer Predicts Disease Recurrence.
- Missing link: inflammation and ovarian Cancer.
- Ovarian surface epitheliectomy in the non-Human primate: continued cyclic ovarian function and limited epithelial replacement.
- Principles of evidence based screening for Cancers.
- The mullerian-inhibiting substance gene is transcribed in human ovarian Carcinomas with and without 19p rearrangements.
- [Residual choledocholithiasis in elective cholecystectomy and choledocholithotomy].
- Microgel assessment of nucleic acid integrity and labeling quality in microarray experiments.
- No BRCA1 germline mutation in a family with uterine papillary serous Carcinoma: a case report.
- Laparoscopic management of adnexal masses the opportunities and the risks.
- Controversies in ovarian Cancer.
- Comparative genomic hybridization of fine needle aspirates from breast Carcinomas.
- Frequent amplification of chromosomal region 20q12-q13 in ovarian Cancer.
- Cytogenetical diagnosis in paraffin-embedded fetoplacental tissue using comparative genomic hybridization.
- Contemporary use of bone densitometry.
- Well-differentiated mucinous Carcinoma of the ovary and a coexisting Brenner tumor both exhibit amplification of 12q14-21 by comparative genomic hybridization.
- Cytogenetics of uterine sarcomas: presentation of eight new cases and review of the literature.
- Genetic aberrations in hypodiploid breast Cancer: frequent loss of chromosome 4 and amplification of cyclin D1 oncogene.
- Identification of TP53 gene mutations in uterine corpus Cancer with short follow-up.
- Karyotypic characteristics of borderline malignant tumors of the ovary: trisomy 12, trisomy 7, and r(1) as nonrandom features.
- Characterisation of seven Human ovarian tumour cell lines.
- Cytogenetic findings in four malignant mixed mesodermal tumors of the ovary.
- Isochromosome 1q as the sole karyotypic abNormality in a Sertoli cell tumor of the ovary.
- Genetic changes in ovarian Cancer.
- Localization of PURA, the gene encoding the sequence-specific single-stranded-DNA-binding protein Pur alpha, to chromosome band 5q31.
- Mapping of the 19p13 breakpoint in an ovarian Carcinoma between the INSR and TCF3 loci.
- Consistent occurrence of a 19p+ marker chromosome and loss of 11p material in ovarian seropapillary cystadenoCarcinomas.
- Simple numerical chromosome aberrations in well-differentiated malignant epithelial tumors.
- Complex karyotypic anomalies, including an i(5p) marker chromosome, in malignant mixed mesodermal tumor of the ovary.
- Trisomy 12 is a consistent chromosomal aberration in benign Ovarian tumors.
- Bilateral ovarian Carcinoma: cytogenetic evidence of unicentric origin.
- Prognostic impact of chromosome aberrations in ovarian Cancer.
- An EcoRI polymorphism at the insulin receptor locus on a fragment comprising exons 4 to 8.
- Chromosome aberrations in 35 primary ovarian Carcinomas.
Schools
University of Belgrade
Oregon Health Sciences University
Procedures Preformed
- Abdominal Hysterectomy With Robotic Assistance
- C-Section
- Colporrhaphy
- Colposcopy
- View All
Conditions Treated
- Adrenogenital Disorders
- Carcinoma in Situ
- Cervical Cancer
- Cervical Polyps
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Portland Monthly Magazine
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACOG)
Education
-
Yale-New Haven Hospital -
University of Belgrade Faculty of Medicine
Drug Facts
| NPI NUMBER | 1770598278 | |
| NPPES Provider LastName | PEJOVIC | |
| NPPES Provider FirstName | TANJA | |
| NPPES Provider ZIPCode | 972393011 | |
| NPPES Provider State | OR | |
| Specialty Description | Gynecological/Oncology | |
| Total Claim Count | 172.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1770598278 |
| Last Name Of The Provider | PEJOVIC |
| First Name Of The Provider | TANJA |
| View All |
Similar Doctors
|
Dr. Robert D. Dyson, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Devansu Tewari, MD |
|
|
Dr. Emily Berry, MD |
|
Dr. William E. Winter III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Larry L. Veltman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joanna M. Cain, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Elizabeth G. Munro, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ann E. Smith Sehdev, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aaron Caughey, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Amy Z. Schmitke, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jason N. Hashima, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Lisa L. McCluskey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janet L. Gibbens, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald G. Marcum, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jim A. Gosewehr, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lisa L. Bayer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonas J. Swartz, MD |